These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 17716175)

  • 41. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 42. Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates.
    Galbiati E; Cassani M; Verderio P; Martegani E; Colombo M; Tortora P; Mazzucchelli S; Prosperi D
    Bioconjug Chem; 2015 Apr; 26(4):680-9. PubMed ID: 25741889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzyme-nanoparticle conjugates for biomedical applications.
    Vertegel AA; Reukov V; Maximov V
    Methods Mol Biol; 2011; 679():165-82. PubMed ID: 20865396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy.
    Huang P; Li Z; Lin J; Yang D; Gao G; Xu C; Bao L; Zhang C; Wang K; Song H; Hu H; Cui D
    Biomaterials; 2011 May; 32(13):3447-58. PubMed ID: 21303717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
    Yu MK; Park J; Jeong YY; Moon WK; Jon S
    Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Towards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multi-modality biomedical imaging.
    Pascu SI; Arrowsmith RL; Bayly SR; Brayshaw S; Hu Z
    Philos Trans A Math Phys Eng Sci; 2010 Aug; 368(1924):3683-712. PubMed ID: 20603377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
    Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peptide-conjugated Nanoparticle Platforms for Targeted Delivery, Imaging, and Biosensing Applications.
    Ilieş BD; Yildiz I; Abbas M
    Chembiochem; 2024 May; 25(10):e202300867. PubMed ID: 38551557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
    Soares AF; Carvalho Rde A; Veiga F
    Nanomedicine (Lond); 2007 Apr; 2(2):183-202. PubMed ID: 17716120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
    Acharya S; Sahoo SK
    Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.
    Rothenfluh DA; Hubbell JA
    Integr Biol (Camb); 2009 Jul; 1(7):446-51. PubMed ID: 20023754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in the synthesis and application of nanoparticles for drug delivery.
    Park W; Na K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(4):494-508. PubMed ID: 25583540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine.
    Jain PK; Huang X; El-Sayed IH; El-Sayed MA
    Acc Chem Res; 2008 Dec; 41(12):1578-86. PubMed ID: 18447366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elastin-like polypeptide based nanoparticles: design rationale toward nanomedicine.
    Smits FC; Buddingh BC; van Eldijk MB; van Hest JC
    Macromol Biosci; 2015 Jan; 15(1):36-51. PubMed ID: 25407963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inorganic nanomedicine--part 1.
    Sekhon BS; Kamboj SR
    Nanomedicine; 2010 Aug; 6(4):516-22. PubMed ID: 20417313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles.
    Cabral RM; Baptista PV
    Expert Rev Mol Diagn; 2014 Nov; 14(8):1041-52. PubMed ID: 25314939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting of nanoparticles: folate receptor.
    Kularatne SA; Low PS
    Methods Mol Biol; 2010; 624():249-65. PubMed ID: 20217601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery.
    Lee KW; Tey BT; Ho KL; Tejo BA; Tan WS
    Mol Pharm; 2012 Sep; 9(9):2415-23. PubMed ID: 22775561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment.
    Kumar A; Ma H; Zhang X; Huang K; Jin S; Liu J; Wei T; Cao W; Zou G; Liang XJ
    Biomaterials; 2012 Feb; 33(4):1180-9. PubMed ID: 22056754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
    Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
    Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.